FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011730> ?p ?o ?g. }

• W4377011730 abstract "Chemotherapeutic regimens containing sorafenib are widely used in salvage treatment for patients with relapsed and refractory acute leukemia, especially those with FLT3-ITD mutations. However, the therapeutic effects in individuals are heterogeneous, and the effective maintenance period is relatively short. Our clinical analysis showed patients with high c-kit (CD117) expression in leukemia cells generally had a better response to sorafenib, but the reason for this finding was not clear. c-kit (CD117) is a receptor tyrosine kinase, and its signal inactivation and hydrolytic metabolism are regulated by the CBL protein, a Ring finger E3 ubiquitin ligase, encoded by the c-CBL gene. And we also found that the c-CBL gene expression in refractory and relapsed patients was significantly lower than that in healthy hematopoietic stem cell donors. Therefore, we assumed that there is a relationship among c-CBL gene function, high expression of c-kit (CD117) and a better clinical response to sorafenib. To confirm this hypothesis, we packaged interfering lentiviruses and overexpressed adenoviruses targeting the c-CBL gene respectively, and infected leukemia cell lines with these viruses to regulate the expression of the c-CBL gene, and observed the subsequent changes of these cells in various biological behaviors. Our results showed when the c-CBL gene was silenced, the cells proliferation was accelerated, drug sensitivity to cytarabine or sorafenib was decreased, and apoptosis ratio was decreased. And all these phenomena were reversed when the gene was overexpressed, which confirmed the expression of c-CBL gene was related to drug resistance in leukemia cells. At last, we explored the possible molecular mechanisms underlying these phenomena." @default.
• W4377011730 created "2023-05-19" @default.
• W4377011730 creator A5000524663 @default.
• W4377011730 creator A5012677359 @default.
• W4377011730 creator A5017769776 @default.
• W4377011730 creator A5047230516 @default.
• W4377011730 creator A5051764626 @default.
• W4377011730 creator A5059747956 @default.
• W4377011730 creator A5070574448 @default.
• W4377011730 date "2023-05-18" @default.
• W4377011730 modified "2023-10-16" @default.
• W4377011730 title "Sorafenib regulates <i>c-CBL</i> gene-mediated chemoresistance in acute myeloid leukemia cells" @default.
• W4377011730 cites W1590057785 @default.
• W4377011730 cites W1902764282 @default.
• W4377011730 cites W1967330415 @default.
• W4377011730 cites W1973681162 @default.
• W4377011730 cites W1981096579 @default.
• W4377011730 cites W1983523339 @default.
• W4377011730 cites W2022164329 @default.
• W4377011730 cites W2034838691 @default.
• W4377011730 cites W2090527870 @default.
• W4377011730 cites W2091755560 @default.
• W4377011730 cites W2096483233 @default.
• W4377011730 cites W2112310108 @default.
• W4377011730 cites W2121587436 @default.
• W4377011730 cites W2137573050 @default.
• W4377011730 cites W2157024381 @default.
• W4377011730 cites W2164084739 @default.
• W4377011730 cites W2172079601 @default.
• W4377011730 cites W2208333084 @default.
• W4377011730 cites W2216341262 @default.
• W4377011730 cites W2301429255 @default.
• W4377011730 cites W2397833923 @default.
• W4377011730 cites W2577115074 @default.
• W4377011730 cites W2581732250 @default.
• W4377011730 cites W2744882241 @default.
• W4377011730 cites W2803953307 @default.
• W4377011730 cites W2807929357 @default.
• W4377011730 cites W2945795979 @default.
• W4377011730 cites W2947013137 @default.
• W4377011730 cites W2961141193 @default.
• W4377011730 cites W2973776959 @default.
• W4377011730 cites W3087431457 @default.
• W4377011730 cites W3093182853 @default.
• W4377011730 cites W3095661274 @default.
• W4377011730 cites W3104374082 @default.
• W4377011730 cites W3121090851 @default.
• W4377011730 cites W3130957322 @default.
• W4377011730 cites W3172575690 @default.
• W4377011730 cites W3206730616 @default.
• W4377011730 doi "https://doi.org/10.1080/16078454.2023.2204620" @default.
• W4377011730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37199372" @default.
• W4377011730 hasPublicationYear "2023" @default.
• W4377011730 type Work @default.
• W4377011730 citedByCount "0" @default.
• W4377011730 crossrefType "journal-article" @default.
• W4377011730 hasAuthorship W4377011730A5000524663 @default.
• W4377011730 hasAuthorship W4377011730A5012677359 @default.
• W4377011730 hasAuthorship W4377011730A5017769776 @default.
• W4377011730 hasAuthorship W4377011730A5047230516 @default.
• W4377011730 hasAuthorship W4377011730A5051764626 @default.
• W4377011730 hasAuthorship W4377011730A5059747956 @default.
• W4377011730 hasAuthorship W4377011730A5070574448 @default.
• W4377011730 hasBestOaLocation W43770117301 @default.
• W4377011730 hasConcept C10205521 @default.
• W4377011730 hasConcept C104317684 @default.
• W4377011730 hasConcept C150194340 @default.
• W4377011730 hasConcept C153911025 @default.
• W4377011730 hasConcept C173396325 @default.
• W4377011730 hasConcept C190283241 @default.
• W4377011730 hasConcept C203014093 @default.
• W4377011730 hasConcept C2776839831 @default.
• W4377011730 hasConcept C2778019345 @default.
• W4377011730 hasConcept C2778041864 @default.
• W4377011730 hasConcept C2778461978 @default.
• W4377011730 hasConcept C2778695046 @default.
• W4377011730 hasConcept C2778729363 @default.
• W4377011730 hasConcept C28328180 @default.
• W4377011730 hasConcept C502942594 @default.
• W4377011730 hasConcept C55493867 @default.
• W4377011730 hasConcept C86803240 @default.
• W4377011730 hasConcept C95444343 @default.
• W4377011730 hasConceptScore W4377011730C10205521 @default.
• W4377011730 hasConceptScore W4377011730C104317684 @default.
• W4377011730 hasConceptScore W4377011730C150194340 @default.
• W4377011730 hasConceptScore W4377011730C153911025 @default.
• W4377011730 hasConceptScore W4377011730C173396325 @default.
• W4377011730 hasConceptScore W4377011730C190283241 @default.
• W4377011730 hasConceptScore W4377011730C203014093 @default.
• W4377011730 hasConceptScore W4377011730C2776839831 @default.
• W4377011730 hasConceptScore W4377011730C2778019345 @default.
• W4377011730 hasConceptScore W4377011730C2778041864 @default.
• W4377011730 hasConceptScore W4377011730C2778461978 @default.
• W4377011730 hasConceptScore W4377011730C2778695046 @default.
• W4377011730 hasConceptScore W4377011730C2778729363 @default.
• W4377011730 hasConceptScore W4377011730C28328180 @default.
• W4377011730 hasConceptScore W4377011730C502942594 @default.
• W4377011730 hasConceptScore W4377011730C55493867 @default.
• W4377011730 hasConceptScore W4377011730C86803240 @default.
• W4377011730 hasConceptScore W4377011730C95444343 @default.

• next